Earnings & Reporting

Hyosung’s impressive H1 2026 results reveal a shrewd strategy: localizing US power grid production for the AI boom while betting on bio-textiles and humanists.

Lithuania's grid operator swung from a €42M loss to a €39M profit. Beyond the numbers lies a story of regulatory finesse and strategic investment fueling energy independence.

As Ascentage Pharma preps its mid-year report, we look beyond the balance sheet at the strategic plays and clinical trials fueling its global oncology ambitions.

Zinzino's 20% sales jump masks a complex global story. While it conquers the Americas, its European home turf is faltering. What does this reveal?

Facing revenue headwinds from currency shifts and regulatory hurdles, China's Jin Medical doubles down on R&D and operational efficiency. A look inside their strategy.

While global industrial markets waver, refractory leader RHI Magnesita proves strategic self-help can deliver powerful growth. Here's how they're doing it.

With a 14.5% profit surge, Renault's finance arm proves its resilience, driving EV adoption and redefining ownership in a volatile automotive market.

As enterprises face spiraling tech complexity, Tangoe's record growth and AI tools reveal a market desperate for control, savings, and actionable intelligence.

NextPlat declares a strategic turnaround, but the real story is its complex model: blending high-margin healthcare with niche satellite tech. Can it deliver?

While flat H1 revenue masks a sharp decline in the Americas, SergeFerrari's European growth and proactive industrial restructuring reveal a masterclass in agility.

The maker of T-Fal and All-Clad posts a staggering €124M loss, yet its operational results and cash flow are soaring. Is this a sign of collapse or recovery?

Sogeclair's H1 2026 results show a 3.1% revenue dip, but a deeper look reveals stable core operations hit by currency swings and a major strategic shift.

After a major restructure, Mauna Kea Technologies posts 44% growth, fueled by its Cellvizio imaging platform and a clever cash-pay model for global expansion.

Allstate's massive Q2 catastrophe bill is more than a financial headline. It's a stark signal of a volatile new normal where extreme weather reshapes risk.

A 44% profit jump on flat volume? NextNRG's AI-driven efficiency shows a future where energy value is created by algorithms, not just output.

With stellar preliminary Q2 results, Virtu is also taking its term loan balance to nearly $2 billion. We look at the strategy behind the numbers.

AB grew AUM to $905B not through market luck, but through inflows. We unpack the strategy, from passive mandates to retail strength, that works in neutral markets.

IGM Financial's record $343B in assets is just the surface. A deeper look reveals a strategy built on ETFs, tech, and key partnerships reshaping the market.

While Mazda's premium CX-90 SUV shatters sales records, the company's overall Canadian sales are down nearly 14% year-to-date, a sign of deep market stress.